![Régis Nouaille](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 5 M $ al 31/07/2026
Régis Nouaille was the founder of Afyren SAS, founded in 2012, holding the title of Chief Executive Officer.
Dr. Nouaille is the founder of Kyanos Biotechnologies SAS, holding the title of Chief Executive Officer.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AFYREN SA 3,99 % | 31/12/2024 | 1.549.250 ( 3,99 % ) | 5 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Kyanos Biotechnologies SAS
 Kyanos Biotechnologies SAS Pharmaceuticals: OtherHealth Technology Develops and sells microalgae supplements | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| AFYREN | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Afyren SAS
 Afyren SAS BiotechnologyHealth Technology Operates as a biotechnology company which produces organic and carboxylic acids | Health Technology |
Kyanos Biotechnologies SAS
Kyanos Biotechnologies SAS Pharmaceuticals: OtherHealth Technology Develops and sells microalgae supplements | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
